TEAD-IN-19
Product Specifications
Target
YAP
Related Pathways
Stem Cells
Bioactivity
TEAD-IN-19 (Compound 1l) is a transcriptional inhibitor of TEAD, showing inhibition rates of 38.5%, 36.2%, 57.8%, and 71.3% for TEAD1, TEAD2, TEAD3, and TEAD4, respectively, at 10 μM. It exhibits strong antiproliferative and antimigratory effects on prostate cancer cell lines and significantly reduces the expression of TEAD-regulated downstream genes. TEAD-IN-19 holds potential for research in the field of cancer therapeutics.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15116007 1 Vial
Lentiviral mouse Exosc6 shRNA (UAS) - Lentiviral mouse Exosc6 shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details 
orb2595896 100 µg
Histone H1.0/H1F0/H1 Mouse Monoclonal Antibody (HRP)
Sign In for Pricing
View Details 